Format

Send to

Choose Destination
Semin Nephrol. 2007 May;27(3):352-62.

Matrix metalloproteinases in kidney disease progression and repair: a case of flipping the coin.

Author information

1
INSERM Unit 702, and Université Pierre et Marie Curie, Paris, France. pierre.ronco@tnn.aphp.fr

Abstract

Matrix metalloproteinases (MMPs) have pleiotropic enzymatic actions that go far beyond degradation of extracellular matrix. Both the multiplicity of their targets and the complexity of their regulation account for a variety of biological effects. In renal diseases, MMP effects may be different and/or opposite during the different phases of the pathology evolution. The major challenge with future therapeutic interventions using MMP inhibitors remains how to accomplish temporal and spatial control of their activity without flipping the coin.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center